NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, vol.18, no.6, pp.441-447, 2008 (SCI-Expanded)
background and aim: The purpose of this study was to evaluate both the predictive value of metabolic syndrome (MS) on no-reflow phenomenon and 30-day clinical outcomes on patients undergoing primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infaction (STEMI).